← Back to Search

Acupuncture for Chemotherapy-Induced Peripheral Neuropathy

Phase 2
Recruiting
Led By Wanqing Iris Zhi, MD, PhD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 4 weeks

Summary

This trial is studying whether acupuncture can help prevent TIPN from getting worse in people receiving taxane.

Who is the study for?
This trial is for English or Spanish-speaking adults over 18 with breast cancer, who are undergoing chemotherapy with taxane and have developed mild nerve pain (TIPN). They must be planning to continue this treatment and agree not to start new pain medications during the study. People can't join if they had neuropathy before starting chemo, are currently on anti-neuropathy meds, or used acupuncture recently.
What is being tested?
The study tests whether real acupuncture can prevent worsening of nerve pain caused by taxane chemotherapy in breast cancer patients. Participants will receive either actual acupuncture (RA) or sham acupuncture (SA), which uses different needles and targets non-specific body areas.
What are the potential side effects?
Acupuncture may cause minor side effects such as bruising, bleeding at needle sites, dizziness, fainting, or infection. However, these are generally rare and considered low-risk compared to other medical treatments.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Neuropathic Pain Scale (NPS)

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: real acupuncture (RA)Active Control1 Intervention
Real Acupuncture weekly till taxane completion
Group II: sham acupuncture (SA)Placebo Group1 Intervention
Sham Acupuncture weekly till taxane completion

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,972 Previous Clinical Trials
597,648 Total Patients Enrolled
206 Trials studying Breast Cancer
82,243 Patients Enrolled for Breast Cancer
Gateway for Cancer ResearchOTHER
45 Previous Clinical Trials
2,407 Total Patients Enrolled
5 Trials studying Breast Cancer
271 Patients Enrolled for Breast Cancer
Wanqing Iris Zhi, MD, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

Media Library

Real Acupuncture Clinical Trial Eligibility Overview. Trial Name: NCT05458284 — Phase 2
Breast Cancer Research Study Groups: real acupuncture (RA), sham acupuncture (SA)
Breast Cancer Clinical Trial 2023: Real Acupuncture Highlights & Side Effects. Trial Name: NCT05458284 — Phase 2
Real Acupuncture 2023 Treatment Timeline for Medical Study. Trial Name: NCT05458284 — Phase 2
~16 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top